- Tytuł:
- Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Infectious Diseases March 2022 22(3):413-425
Czasopismo naukowe